Correlation Between Pmv Pharmaceuticals and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Arcturus Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Arcturus Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pmv and Arcturus is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Arcturus Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Arcturus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 2.24 times less risky than Arcturus Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Arcturus Therapeutics Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,800 in Arcturus Therapeutics Holdings on September 2, 2024 and sell it today you would earn a total of 34.00 from holding Arcturus Therapeutics Holdings or generate 1.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Arcturus Therapeutics |
Pmv Pharmaceuticals and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Arcturus Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |